newsfilter
← Latest News
PR Newswire·

PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

SALT LAKE CITY, May 13, 2022 /PRNewswire/ -- PolarityTE, Inc. (NASDAQ:PTE) today announced that the U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company's open IND.